Evidence map›Paper›PMID 39940060›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2025

Guolin Wang, Qianhe Xu, Yinuo Liu, Huatao Wang, Fei Yang, Zhenfeng Liu, Xinhui Su

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Mesenteric Castleman disease: Two case reports and review of literature.World journal of gastrointestinal surgery · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guolin Wang *Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Qianhe Xu *Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Yinuo LiuDepartment of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Huatao WangDepartment of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Fei YangDepartment of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Zhenfeng LiuDepartment of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China. zhenfeng19792003@zju.edu.cn.
Xinhui SuDepartment of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China. suxinhui@zju.edu.cn.

Funding

Natural Science Foundation of Zhejiang Province LTGY23H180014Zhejiang Medical and Health Science and Technology Program 2023KY694
6 · The paper itself

Abstract

backgroundCastleman disease (CD) is a rare lymphoproliferative disorder. This study is to evaluate the correlation between

methodsWe retrospectively enrolled 93 patients with newly diagnosed CD. Traditional semi-quantitative

resultsA total of 20 unicentric CD (UCD) and 73 multicentric CD (MCD) cases were included, with the highest SUV

conclusionsSLR is closely related to clinical features of CD, and can relatively effectively differentiate the severity of CD and assist in the clinical risk stratification of iMCD.

Indexed as

Castleman DiseasePositron Emission Tomography Computed TomographyAdolescentAdultAgedCorrelation of DataFemaleFluorodeoxyglucose F18HumansLiverLymph NodesMaleMiddle AgedOrgan SizePatient AcuityRetrospective StudiesFluorodeoxyglucose F1818F-FDG PET/CTCastleman diseaseDisease severitymetabolic parametersSpleen to liver ratio (SLR)

Identifiers

PMID39940060
PMCPMC11823125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.